معرفی
Maria Kalamvokis, PhD is an Associate Professor in the Department of Microbiology, Molecular Genetics and Immunology at the University of Kansas School of Medicine. Her research focuses on understanding how herpes simplex virus (HSV) counteracts host antiviral responses, particularly innate immunity, which plays a critical role in controlling HSV replication, spread, latency, and disease severity. She leads a laboratory investigating viral mechanisms of immune evasion and pathogenesis.
Dr. Kalamvokis received her educational training through the following path:
- BSc from National and Kapodistrian University of Athens, Greece
- PhD in Virology from National and Kapodistrian University of Athens, Greece & Hellenic Pasteur Institute
- Post Doctoral Fellowship at the University of Chicago
Dr. Kalamvokis's research program emphasizes three main directions: 1) The impact of HSV-1 infection on intercellular communication mediated by extracellular vesicles (EVs), hypothesizing that HSV-1 alters EV properties and functions with consequences for viral infection and pathogenesis; 2) The mechanism by which HSV-1 counteracts pattern recognition receptors (PRRs), with significance stemming from links between PRR mutations and severe HSV diseases; 3) The functions of the immediate-early protein ICP0, particularly its role as an E3 ubiquitin ligase with essential functions in early infection stages, including activating viral gene transcription and counteracting host antiviral responses. Her laboratory has discovered novel ICP0 functions related to endocytosis of cell surface receptors and down-regulation of autophagy adaptors.
Analysis of Dr. Kalamvokis's recent publications reveals a strong focus on HSV-1 mechanisms of immune evasion, particularly through manipulation of the STING pathway, extracellular vesicle communication, and autophagy. Her work spans from basic molecular mechanisms to implications for viral pathogenesis and disease severity. A notable expansion in her research portfolio includes investigations into coronavirus biology, particularly SARS-CoV-2, examining how viral proteins affect host cellular processes like intracellular trafficking, autophagy, and interactions with other viruses like HIV-1. This cross-viral research demonstrates the interdisciplinary nature of her laboratory's approach to understanding viral pathogenesis.
Dr. Kalamvokis is an active member of several professional organizations:
- American Society of Microbiology (Member, 2016-Present)
- American Society of Virology (Member, 2016-Present)
- Center for Viral Pathogenesis - KUMC (Member, 2016-Present)
While specific grant information is not detailed in the provided text, Dr. Kalamvokis's extensive publication record spanning multiple high-impact journals suggests successful grant funding to support her research program. Her laboratory appears to maintain collaborations across multiple institutions, as evidenced by co-authorship patterns in her publications. She has mentored numerous researchers who have contributed to her laboratory's output, though specific student names are not provided in the available information.
Dr. Kalamvokis leads a research laboratory focused on viral pathogenesis, with particular expertise in herpes simplex virus mechanisms. Her lab investigates how HSV-1 manipulates host cellular processes including extracellular vesicle communication, innate immune signaling (particularly the STING pathway), and autophagy. The laboratory employs a range of molecular virology, cell biology, and immunology techniques to elucidate viral mechanisms of immune evasion. Her team's recent expansion into coronavirus research demonstrates the lab's adaptability to emerging viral threats while maintaining its core focus on viral pathogenesis mechanisms.
